ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
Adicet Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$4.53−0.04 (-0.88%)
Close on Oct 19, 2026
- Market cap
- $48.68M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$122.11MFY2025